Interaction of common azole antifungals with P glycoprotein
about
Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonistsClinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions.Effect of ketoconazole on the pharmacokinetics of udenafil in healthy Korean subjects.Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone.Itraconazole and domperidone: a placebo-controlled drug interaction study.Pharmacokinetic interaction between itraconazole and metformin in rats: competitive inhibition of metabolism of each drug by each other via hepatic and intestinal CYP3A1/2.CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics.Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir.Sucralose, a synthetic organochlorine sweetener: overview of biological issuesChapter 11 - Reconstitution of membrane proteins in phospholipid bilayer nanodiscsHuman pharmacogenomic variations and their implications for antifungal efficacy.Itraconazole--perspectives for the management of invasive aspergillosis.Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding proteinEffects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers.Influence of ketoconazole on azimilide pharmacokinetics in healthy subjects.Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide.Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide.Drug-drug interactions of antifungal agents and implications for patient care.Molecular model of the outward facing state of the human P-glycoprotein (ABCB1), and comparison to a model of the human MRP5 (ABCC5)Drug interactions during therapy with three major groups of antimicrobial agents.Drug-drug interactions involving membrane transporters in the human kidney.Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.Molecular pharmacokinetics of catharanthus (vinca) alkaloids.CNS pharmacokinetics of antifungal agents.Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents.Binding site of ABC transporter homology models confirmed by ABCB1 crystal structureTreatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects.Interactions between antifungal and antiretroviral agents.Management of drug and food interactions with azole antifungal agents in transplant recipients.Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics.Transporter-mediated drug-drug interactions.Azole interactions with multidrug therapy in pediatric oncology.Psychotropic drug-drug interactions involving P-glycoprotein.Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer's disease management.Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.
P2860
Q24632161-21A79CE4-5BB4-4A36-8A21-3B79BDD31B28Q30234940-F5E83F4B-3C8B-444A-8719-6E33244F79E6Q33692838-E9B19F06-703C-423A-877D-E2C32269A8D7Q34019354-252E2785-3961-4E69-9582-B9F4C9BC7961Q34261356-1C3E54EA-43B1-4A98-90A5-70CFF3B0DFD8Q34356103-CA73BD6D-00D1-4D6C-886A-CD85E67AE4CFQ34437996-7412642B-6516-4A7F-8674-2FE9BB8990E6Q34474583-CDE7F9D9-FD59-4129-82D1-E128FC84C02CQ34532546-ED1B4D0D-3748-4373-89F2-4235C40A93E6Q34563883-BE1D0008-BCA7-4FD4-B6EB-1F0FB3A3E6D4Q34633457-CFA0AD76-6728-4341-8210-0B6FE4508F1BQ34657381-B6CEB4BE-786A-4119-BB5E-53E36108CDF5Q35012211-418361D4-F78E-418B-B74F-DF2932032AD1Q35070838-C5775340-B4ED-4412-849D-55B108317C01Q35105394-6B5049CD-726A-4355-8D3D-BFF7F5628755Q35252021-5FB3E727-95EB-4A4E-B232-4F72E6607129Q35635971-4F15A02F-EAF7-4CEA-BC6D-6F2D98AF99EEQ35826541-0D1458CE-0A3C-4154-8E13-02C02B839011Q35827146-E3060E5E-00F8-4E9F-AD9F-65584670570CQ35827197-3ED5B807-5DA2-4D05-8BA7-BB46828997F3Q36283721-84E056C7-CAFF-43A6-BE1B-B02275518770Q36398058-019244D6-D020-4804-B61F-87AF598A7A54Q36429699-96B15572-3567-4998-A753-2B3DA5949CF7Q36543091-5360D08E-5365-4D5A-93FB-AAF4A5292EE1Q36662912-BC52200D-31FD-40BC-A1DC-9E98B63FF107Q36795140-AD15A96B-D3D2-4419-A73A-62E7BB58301BQ36909333-99EA211B-94D3-4F7A-A80C-8093C0508A33Q37157893-FAD17DB2-9C24-4D42-80FF-05C4DF8EE46AQ37355834-C8EB9875-77ED-43C2-B786-3034D3F30B29Q37469829-B903EB24-1210-4039-891B-6AA168734779Q37631841-CD3AB284-2E4A-4413-8CE8-266A20B4AE2FQ37719545-04D61FAD-07A2-4BF6-A777-78B397BB1C93Q37775009-52ECC8C2-8E52-4F56-9F7F-5F164D4678E1Q37904672-5A4E3FC3-4E3B-4F65-8BE5-2E69C2CCC698Q37905033-18B92470-D8D1-489B-8D22-FA5566787B48Q38015710-1BBFFF4B-B514-49C0-AF6E-F80CF837079BQ38047816-1245D6B4-D34E-4E14-B386-B89BD5DB56C2Q38183877-9D8CA086-7DD9-46D6-B3F7-09D2E3FC2EF5Q38248506-985638A2-967D-419D-9AD5-8381C9167C4CQ38516237-5C25BF9B-5F66-449F-874B-79A5FC69D0EE
P2860
Interaction of common azole antifungals with P glycoprotein
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Interaction of common azole antifungals with P glycoprotein
@ast
Interaction of common azole antifungals with P glycoprotein
@en
Interaction of common azole antifungals with P glycoprotein
@nl
type
label
Interaction of common azole antifungals with P glycoprotein
@ast
Interaction of common azole antifungals with P glycoprotein
@en
Interaction of common azole antifungals with P glycoprotein
@nl
prefLabel
Interaction of common azole antifungals with P glycoprotein
@ast
Interaction of common azole antifungals with P glycoprotein
@en
Interaction of common azole antifungals with P glycoprotein
@nl
P2093
P2860
P1476
Interaction of common azole antifungals with P glycoprotein
@en
P2093
Christopher N Casciano
Er-jia Wang
Robert P Clement
William W Johnson
P2860
P304
P356
10.1128/AAC.46.1.160-165.2002
P407
P577
2002-01-01T00:00:00Z